查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1652703

定量吸入器市场：全球产业分析、规模、份额、成长、趋势和预测，2025-2032 年

Metered Dose Inhalers Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 186 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research 最近发布了一份关于全球定量吸入器（MDI）市场的综合报告。该报告对市场驱动因素、趋势、机会、驱动因素和挑战等关键市场动态进行了全面的评估，并对市场结构提供了详细的见解。本研究报告提供独家资料和统计数据，概述了 2025 年至 2032 年全球定量吸入器市场的预期成长轨迹。

关键见解

  • 定量吸入器市场规模（2025年预测）：303亿美元
  • 预计市场价值（2032 年）：385 亿美元
  • 全球市场成长率（2025-2032 年复合年增长率）：3.5%

定量吸入器市场：研究范围

定量吸入器（MDI）对于治疗气喘、慢性阻塞性肺病（COPD）和其他肺部疾病等呼吸系统疾病至关重要。这些吸入器旨在以一致且可控的方式向肺部输送固定量的药物。这个市场包括传统的 MDI 和更新、更先进的吸入器设备，以满足对高效、精确的药物输送系统日益增长的需求。市场成长的主要动力是呼吸系统疾病盛行率的不断上升、污染水平的不断上升以及对吸入疗法益处的认识不断提高。吸入器技术的进步，例如呼吸驱动吸入器的引入和数位健康解决方案的集成，预计将进一步推动市场需求。

市场驱动因素：

全球定量吸入器市场受到多种关键因素的推动，例如气喘和 COPD 盛行率的上升，尤其是在老龄化人口中。皮质类固醇和支气管扩张剂等其他药物的合併使用不断增加，促进了 MDI 的广泛使用。人们对坚持吸入疗法的重要性的认识不断提高，以及各种旨在提高易用性的设备的出现，进一步推动了市场扩张。此外，吸入器设计方面的技术进步，例如剂量计数器、患者依从性追踪系统和呼吸驱动装置的开发，使得这些吸入器对使用者来说更加方便和可靠。

市场限制：

儘管成长前景乐观，但定量吸入器市场仍面临先进吸入器设备高成本以及设备易用性问题等挑战。低收入地区的患者可能面临负担能力的挑战，尤其是对于整合技术的新型设备。此外，由于传统吸入器中使用的推进剂会导致臭氧层破坏，因此 MDI 的使用也会带来环境问题。随着监管机构推动更环保的替代品，製造商必须适应这些环境挑战，同时确保其产品的安全有效。

市场机会：

由于行动应用程式和远端监控系统等数位健康技术的集成，定量吸入器市场提供了巨大的成长机会，这些技术可以改善患者管理并提高对治疗方法的依从性。此外，对个人化医疗和以患者为中心的治疗方法的日益关注为吸入器设计和功能的创新提供了新的途径。与製药公司的策略伙伴关係以及对环保替代品的日益增长的需求是行业参与者探索的关键机会。

本报告探讨的关键问题

  • 推动全球定量吸入器市场成长的关键因素有哪些？
  • 技术进步如何改变定量吸入器市场的竞争格局？
  • 市场面临的主要挑战是什么？
  • 谁是定量吸入器市场的领导者，他们采取什么策略来维持市场领导地位？
  • 全球定量吸入器市场有哪些新兴趋势与前景？

目录

第一章执行摘要

第二章 市场概况

  • 市场范围和定义
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
    • 任务
    • 主要趋势
  • 类型生命週期分析
  • 定量吸入器市场：价值链
    • 原物料供应商名单
    • 製造商列表
    • 经销商名单
    • 应用程式列表
    • 盈利分析
  • 波特五力分析
  • 地缘政治紧张局势：市场影响
  • 宏观经济因素
    • 全球产业展望
    • 全球GDP成长前景
    • 全球母市场概览
  • 预测因子－相关性和影响力
  • 监管和技术格局

第 3 章。

  • 主要亮点
    • 市场规模（单位）预测
    • 市场规模及与前一年同期比较率
    • 绝对商机
  • 市场规模（百万美元）分析及预测
    • 2019 年至 2023 年历史市场规模分析
    • 目前市场规模预测，2025-2032
  • 全球定量吸入器市场展望：类型
    • 简介/主要发现
    • 2019 年至 2023 年历史市场规模（百万美元）和销售（单位）分析，按类型
    • 当前市场规模（百万美元）及销售量（单位）分析及预测，2025-2032 年，依类型
      • 紧急吸入器
      • 长效支气管扩张剂吸入器
  • 市场吸引力分析：类型
  • 全球定量吸入器市场展望：最终用户
    • 简介/主要发现
    • 2019 年至 2023 年历史市场规模（百万美元）和销售（单位）分析，按最终用户
    • 目前市场规模（百万美元）及销售量（单位）分析及预测，2025-2032，依最终用户划分
      • 居家护理
      • 医院
      • 诊所
  • 市场吸引力分析：最终用户

4. 全球定量吸入器市场展望-区域

  • 主要亮点
  • 2019 年至 2023 年按地区分類的历史市场规模（百万美元）和销售量（单位）分析
  • 当前市场规模（百万美元）及销售量（单位）分析及预测，2025-2032 年，依地区划分
    • 北美洲
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：地区

第 5 章。

6. 欧洲定量吸入器市场展望：历史（2019-2023）与预测（2025-2032）

第 7 章。

8. 南亚和大洋洲定量吸入器市场展望：历史（2019-2023 年）和预测（2025-2032 年）

第 9 章拉丁美洲定量吸入器市场展望：历史（2019-2023 年）和预测（2025-2032 年）

第 10 章中东和非洲定量吸入器市场展望：历史（2019-2023 年）和预测（2025-2032 年）

第十一章 竞争格局

  • 2024 年市场占有率分析
  • 市场结构
    • 市场竞争加剧图
    • 具竞争力的类比类比IC
    • 表观霉菌体积
  • 公司简介（详情－概述、财务状况、策略、最新发展）
    • Cipla Inc.
    • Presspart Manufacturing Ltd
    • Midascare Pharmaceuticals Pvt. Ltd
    • Beximco Pharma Ltd.
    • GlaxoSmithKline Pharmaceuticals Ltd.
    • 3M Pharmaceuticals Pty Ltd.
    • Biocare Manufacturing Sdn Bhd.
    • Anomatic Innovation &Design Center &Manufacturing
    • Aristo Pharma Ltd.

第十二章 附录

  • 调查方法
  • 调查前提
  • 首字母缩写和简称
简介目录
Product Code: PMRREP33723

Persistence Market Research has recently released a comprehensive report on the worldwide market for metered dose inhalers (MDIs). The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global metered dose inhalers market from 2025 to 2032.

Key Insights:

  • Metered Dose Inhalers Market Size (2025E): USD 30.30 Billion
  • Projected Market Value (2032F): USD 38.5 Billion
  • Global Market Growth Rate (CAGR 2025 to 2032):3.5%

Metered Dose Inhalers Market - Report Scope:

Metered dose inhalers (MDIs) are vital in the management of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and other lung disorders. These inhalers are designed to deliver a specific dose of medication to the lungs in a consistent and controlled manner. The market includes both conventional MDIs and newer, more advanced inhaler devices, addressing the growing need for efficient and accurate drug delivery systems. Market growth is primarily driven by the increasing prevalence of respiratory diseases, rising pollution levels, and growing awareness about the benefits of inhaler therapy. Advancements in inhaler technologies, such as the introduction of breath-actuated inhalers and the integration of digital health solutions, are expected to further boost market demand.

Market Growth Drivers:

The global metered dose inhalers market is propelled by several key factors, including the rising incidence of asthma and COPD, particularly in aging populations. The increasing use of MDIs in combination with other therapies, such as corticosteroids and bronchodilators, has contributed to their widespread adoption. The growing awareness about the importance of adherence to inhalation therapy and the availability of various device types designed to improve usability further drive market expansion. Additionally, technological advancements in inhaler design, such as the development of dose counters, patient compliance tracking systems, and breath-actuated devices, have made these inhalers more convenient and reliable for users.

Market Restraints:

Despite the positive growth outlook, the metered dose inhalers market faces challenges related to the high cost of advanced inhaler devices and issues surrounding device usability. Patients in low-income regions may face affordability issues, particularly for newer devices with integrated technologies. Moreover, the use of MDIs has been associated with environmental concerns due to the propellants used in traditional inhalers, which contribute to ozone depletion. As regulatory bodies push for greener alternatives, manufacturers will need to adapt to these environmental challenges while ensuring the safety and efficacy of their products.

Market Opportunities:

The metered dose inhalers market presents significant growth opportunities driven by the integration of digital health technologies, such as mobile apps and remote monitoring systems, which allow for improved patient management and better adherence to treatment regimens. Moreover, the increasing focus on personalized medicine and patient-centric approaches to therapy offers new avenues for innovation in inhaler design and functionality. Strategic partnerships with pharmaceutical companies and the growing demand for eco-friendly alternatives are key opportunities for industry players to explore.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the metered dose inhalers market globally?
  • How are technological advancements reshaping the competitive landscape of the metered dose inhalers market?
  • What are the key challenges facing the market, and how can companies overcome them?
  • Who are the leading players in the metered dose inhalers market, and what strategies are they employing to maintain market leadership?
  • What are the emerging trends and future prospects in the global metered dose inhalers market?

Competitive Intelligence and Business Strategy:

Leading players in the global metered dose inhalers market, including companies such as GlaxoSmithKline, AstraZeneca, and Boehringer Ingelheim, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies are heavily investing in R&D to develop new inhaler technologies, such as combination inhalers and eco-friendly MDIs that use alternative propellants. Collaborations with healthcare providers and pharmaceutical companies to offer combination therapies and improve patient adherence are critical strategies to sustain growth in the market.

Key Companies Profiled:

  • GlaxoSmithKline
  • AstraZeneca
  • Boehringer Ingelheim
  • Merck & Co.
  • Novartis AG
  • Cipla Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Hovione
  • 3M Health Care
  • Pfizer Inc.

Metered Dose Inhalers Market Research Segmentation

By Type:

  • Reliever Inhaler
  • Long-acting bronchodilators Inhaler

By End Use:

  • Homecare
  • Hospitals
  • Clinics

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Metered Dose Inhalers Market Snapshot, 2025 - 2032
  • 1.2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Type Lifecycle Analysis
  • 2.4. Metered Dose Inhalers Market: Value Chain
    • 2.4.1. List of Raw Material Supplier
    • 2.4.2. List of Manufacturers
    • 2.4.3. List of Distributors
    • 2.4.4. List of Applications
    • 2.4.5. Profitability Analysis
  • 2.5. Porter Five Force's Analysis
  • 2.6. Geopolitical Tensions: Market Impact
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview
  • 2.8. Forecast Factors - Relevance and Impact
  • 2.9. Regulatory and Technology Landscape

3. Global Metered Dose Inhalers Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 3.1. Key Highlights
    • 3.1.1. Market Volume (Units) Projections
    • 3.1.2. Market Size and Y-o-Y Growth
    • 3.1.3. Absolute $ Opportunity
  • 3.2. Market Size (US$ Mn) Analysis and Forecast
    • 3.2.1. Historical Market Size Analysis, 2019 - 2023
    • 3.2.2. Current Market Size Forecast, 2025 - 2032
  • 3.3. Global Metered Dose Inhalers Market Outlook: Type
    • 3.3.1. Introduction / Key Findings
    • 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Type, 2019 - 2023
    • 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2025 - 2032
      • 3.3.3.1. Reliever Inhaler
      • 3.3.3.2. Long-Acting Bronchodilators Inhaler
  • 3.4. Market Attractiveness Analysis: Type
  • 3.5. Global Metered Dose Inhalers Market Outlook: End User
    • 3.5.1. Introduction / Key Findings
    • 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2019 - 2023
    • 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
      • 3.5.3.1. Homecare
      • 3.5.3.2. Hospitals
      • 3.5.3.3. Clinics
  • 3.6. Market Attractiveness Analysis: End User

4. Global Metered Dose Inhalers Market Outlook: Region

  • 4.1. Key Highlights
  • 4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2019 - 2023
  • 4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2025 - 2032
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. East Asia
    • 4.3.4. South Asia and Oceania
    • 4.3.5. Latin America
    • 4.3.6. Middle East & Africa (MEA)
  • 4.4. Market Attractiveness Analysis: Region

5. North America Metered Dose Inhalers Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 5.1. Key Highlights
  • 5.2. Pricing Analysis
  • 5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 5.3.1. By Country
    • 5.3.2. By Type
    • 5.3.3. By End User
  • 5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 5.4.1. U.S.
    • 5.4.2. Canada
  • 5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2025 - 2032
    • 5.5.1. Reliever Inhaler
    • 5.5.2. Long-Acting Bronchodilators Inhaler
  • 5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
    • 5.6.1. Homecare
    • 5.6.2. Hospitals
    • 5.6.3. Clinics
  • 5.7. Market Attractiveness Analysis

6. Europe Metered Dose Inhalers Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 6.3.1. By Country
    • 6.3.2. By Type
    • 6.3.3. By End User
  • 6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. U.K.
    • 6.4.4. Italy
    • 6.4.5. Spain
    • 6.4.6. Russia
    • 6.4.7. Turkey
    • 6.4.8. Rest of Europe
  • 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2025 - 2032
    • 6.5.1. Reliever Inhaler
    • 6.5.2. Long-Acting Bronchodilators Inhaler
  • 6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
    • 6.6.1. Homecare
    • 6.6.2. Hospitals
    • 6.6.3. Clinics
  • 6.7. Market Attractiveness Analysis

7. East Asia Metered Dose Inhalers Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 7.3.1. By Country
    • 7.3.2. By Type
    • 7.3.3. By End User
  • 7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. South Korea
  • 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2025 - 2032
    • 7.5.1. Reliever Inhaler
    • 7.5.2. Long-Acting Bronchodilators Inhaler
  • 7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
    • 7.6.1. Homecare
    • 7.6.2. Hospitals
    • 7.6.3. Clinics
  • 7.7. Market Attractiveness Analysis

8. South Asia & Oceania Metered Dose Inhalers Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 8.3.1. By Country
    • 8.3.2. By Type
    • 8.3.3. By End User
  • 8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 8.4.1. India
    • 8.4.2. Southeast Asia
    • 8.4.3. ANZ
    • 8.4.4. Rest of South Asia & Oceania
  • 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2025 - 2032
    • 8.5.1. Reliever Inhaler
    • 8.5.2. Long-Acting Bronchodilators Inhaler
  • 8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
    • 8.6.1. Homecare
    • 8.6.2. Hospitals
    • 8.6.3. Clinics
  • 8.7. Market Attractiveness Analysis

9. Latin America Metered Dose Inhalers Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 9.3.1. By Country
    • 9.3.2. By Type
    • 9.3.3. By End User
  • 9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2025 - 2032
    • 9.5.1. Reliever Inhaler
    • 9.5.2. Long-Acting Bronchodilators Inhaler
  • 9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
    • 9.6.1. Homecare
    • 9.6.2. Hospitals
    • 9.6.3. Clinics
  • 9.7. Market Attractiveness Analysis

10. Middle East & Africa Metered Dose Inhalers Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 10.3.1. By Country
    • 10.3.2. By Type
    • 10.3.3. By End User
  • 10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 10.4.1. GCC
    • 10.4.2. Egypt
    • 10.4.3. South Africa
    • 10.4.4. Northern Africa
    • 10.4.5. Rest of Middle East & Africa
  • 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2025 - 2032
    • 10.5.1. Reliever Inhaler
    • 10.5.2. Long-Acting Bronchodilators Inhaler
  • 10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
    • 10.6.1. Homecare
    • 10.6.2. Hospitals
    • 10.6.3. Clinics
  • 10.7. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2024
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping By Market
    • 11.2.2. Competition Analog IC
    • 11.2.3. Apparent Type Capacity
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. Cipla Inc.
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Type
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. Presspart Manufacturing Ltd
      • 11.3.2.1. Overview
      • 11.3.2.2. Segments and Type
      • 11.3.2.3. Key Financials
      • 11.3.2.4. Market Developments
      • 11.3.2.5. Market Strategy
    • 11.3.3. Midascare Pharmaceuticals Pvt. Ltd
      • 11.3.3.1. Overview
      • 11.3.3.2. Segments and Type
      • 11.3.3.3. Key Financials
      • 11.3.3.4. Market Developments
      • 11.3.3.5. Market Strategy
    • 11.3.4. Beximco Pharma Ltd.
      • 11.3.4.1. Overview
      • 11.3.4.2. Segments and Type
      • 11.3.4.3. Key Financials
      • 11.3.4.4. Market Developments
      • 11.3.4.5. Market Strategy
    • 11.3.5. GlaxoSmithKline Pharmaceuticals Ltd.
      • 11.3.5.1. Overview
      • 11.3.5.2. Segments and Type
      • 11.3.5.3. Key Financials
      • 11.3.5.4. Market Developments
      • 11.3.5.5. Market Strategy
    • 11.3.6. 3M Pharmaceuticals Pty Ltd.
      • 11.3.6.1. Overview
      • 11.3.6.2. Segments and Type
      • 11.3.6.3. Key Financials
      • 11.3.6.4. Market Developments
      • 11.3.6.5. Market Strategy
    • 11.3.7. Biocare Manufacturing Sdn Bhd.
      • 11.3.7.1. Overview
      • 11.3.7.2. Segments and Type
      • 11.3.7.3. Key Financials
      • 11.3.7.4. Market Developments
      • 11.3.7.5. Market Strategy
    • 11.3.8. Anomatic Innovation & Design Center & Manufacturing
      • 11.3.8.1. Overview
      • 11.3.8.2. Segments and Type
      • 11.3.8.3. Key Financials
      • 11.3.8.4. Market Developments
      • 11.3.8.5. Market Strategy
    • 11.3.9. Aristo Pharma Ltd.
      • 11.3.9.1. Overview
      • 11.3.9.2. Segments and Type
      • 11.3.9.3. Key Financials
      • 11.3.9.4. Market Developments
      • 11.3.9.5. Market Strategy

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations